| Value | ₹120.9 Cr |
|---|---|
| Execution period | 48 months |
NSE filing, NSE: PANACEABIO. Summary written from the filing by ALFA Finder's alert engine.
Panacea Biotec Ltd: key numbers
- Share price
- ₹325.10
- Market cap
- ₹1,991 Cr
- Revenue (annual)
- ₹639.8 Cr
- Net profit (annual)
- ₹-5.37 Cr
- P/E (TTM)
- -279.7×Sector 46.1×
- Promoter holding
- 72.48%+0.00% QoQ
- FII holding
- 2.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Panacea Biotec Ltd
All →Panacea Biotec Annual General Meeting
Panacea Biotec held its 42nd Annual General Meeting on September 29, 2026, where members considered and adopted various financial and operational business items.
Panacea Biotec Legal & Regulatory
Panacea Biotec received two Income Tax demand orders totaling ₹4.32 Crore for alleged income misreporting. The company disputes the demand and plans to file an appeal.
- Value
- ₹4.32 Cr
Panacea Biotec Legal & Regulatory
Panacea Biotec received four income tax demand orders totaling ₹9.82 Crore for alleged misreporting. The company contests this as non-maintainable and plans to appeal.
- Value
- ₹9.82 Cr
Panacea Biotec Other Announcement
Panacea Biotec sent reminder letters to physical shareholders requesting PAN and KYC updates per SEBI circulars. No transaction or business event is involved.
Panacea Biotec Annual General Meeting
Panacea Biotec Limited issued the notice for its 42nd Annual General Meeting scheduled for September 29, 2026, via video conferencing. Shareholders can participate through remote e-voting.
Panacea Biotec Other Announcement
Panacea Biotec Limited has submitted its monthly share dematerialization report for August 2026. This is a routine regulatory compliance filing under SEBI Regulation 74(5).
Other new order win announcements
All →Rail Vikas Nigam Bags ₹0.55 Cr Order from Ministry of External Affairs
Rail Vikas Nigam received a Letter of Award from the Ministry of External Affairs for a Rs.0.55 Crore DPR for a professional and technical education centre in Seychelles. Execution is due within six months.
- Value
- ₹0.55 Cr
- From
- Ministry of External Affairs
- Execution
- 6 Months
Shelter Pharma Bags ₹0.22 Cr Order from First Vet Veterinary Medicines Trading L.L.C
Shelter Pharma won a USD 23,300 (Rs 0.22 Crore) export order from First Vet, UAE. Ordinary course business, executable per the purchase order schedule.
- Value
- ₹0.22 Cr
- From
- First Vet Veterinary Medicines Trading L.L.C
- Execution
- Within the mutually agreed timelines as per the purchase order schedule
Shelter Pharma Bags ₹0.1 Cr Order from Genet International
Shelter Pharma won a Rs.0.10 Crore order from Genet International in Bangladesh. It covers 10,000 boxes in the normal course of business.
- Value
- ₹0.10 Cr
- From
- Genet International
- Execution
- Within mutually agreed timelines as per the purchase order schedule
Shelter Pharma Bags ₹3.15 Cr Order from Taha Drugs & Chemicals Co. Ltd.
Shelter Pharma Ltd received an international order from Taha Drugs & Chemicals Co. Ltd. worth Rs.3.15 Crore (USD 3,30,975). Execution follows mutually agreed purchase order schedules.
- Value
- ₹3.15 Cr
- From
- Taha Drugs & Chemicals Co. Ltd.
- Execution
- Within mutually agreed timelines as per purchase order schedule
Shelter Pharma Bags ₹3.47 Cr Order from Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines...
Shelter Pharma received export orders worth Rs. 3.47 Crore from three overseas buyers. Execution follows mutually agreed purchase-order schedules, in the normal course of business.
- Value
- ₹3.47 Cr
- From
- Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines Trading L.L.C; Genet International
- Execution
- As per mutually agreed purchase order schedules
Workmates Core2Cloud Solution Bags ₹2.47 Cr Order from A leading retail broking and financial services company
Workmates Core2Cloud Solution has received a work order from a leading retail broking and financial services company for AWS cloud migration. Initial order value is USD 260,000, with ARR expected to ramp up over about 24 months.
- Value
- ₹2.47 Cr
- From
- A leading retail broking and financial services company
- Execution
- Approximately 24 months from commencement of the engagement